Top stories
More news
ESG & Sustainability
Why the future of climate change solutions hinges on Stem careers
Subscribe & Follow
Trending
#AfricaMonth
Advertise your job vacancies
Experts seek WHO nod for postpartum haemorrhage drug
A drug many health experts say can drastically cut postpartum haemorrhage - the leading cause of maternal deaths in the developing world - will be in the spotlight this month during the World Health Organization's (WHO) biennial review of its model list of essential medicines.
Health groups are urging WHO to include misoprostol for the prevention and management of postpartum haemorrhage (PPH), or excessive bleeding following childbirth. WHO in 2009 denied misoprostol for prevention of PPH but proponents hope new evidence presented for the 21-25 March WHO meeting in the Ghanaian capital Accra will bring a change. Read the article.
